NCT02935569

Brief Summary

This study hypothesizes that in patients undergoing whole brain radiotherapy, a compression headband will decrease the percentage of patients with significant hair loss following radiation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2012

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 12, 2012

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2014

Completed
2.2 years until next milestone

First Posted

Study publicly available on registry

October 17, 2016

Completed
Last Updated

February 28, 2017

Status Verified

February 1, 2017

Enrollment Period

2.3 years

First QC Date

October 12, 2012

Last Update Submit

February 27, 2017

Conditions

Keywords

AlopeciaRadiotherapy

Outcome Measures

Primary Outcomes (1)

  • Change in Hair loss defined as grade 1 (thinning or patchy) or grade 2 (complete) alopecia (hair loss), as per Common Toxicity Criteria for Adverse Effects (CTCAE) version 3

    The primary outcome of this study will be the presence of "significant hair loss" by 6 weeks after the completion of whole brain radiation. This will be defined as grade 1 (thinning or patchy) or grade 2 (complete) alopecia (hair loss), as per Common Toxicity Criteria for Adverse Effects (CTCAE) version 3. The amount of hair loss will be evaluated at the following time points. * Before whole brain radiation * six weeks following radiation

    baseline to 6 weeks

Secondary Outcomes (3)

  • Temporary compression headband side effects (Nausea, Headache, Redness, Tingling) in patients undergoing whole brain radiation

    6 weeks

  • Timing of hair regrowth

    one year

  • Acute hypoxia in the scalp of normal volunteers caused by compression headband (if present, to what degree?) as measured by a transcutaneous oxygen pressure monitor

    1 hour

Study Arms (1)

Compression Headband

EXPERIMENTAL

a compression headband, placed only at the time of irradiation

Device: Compression HeadBand

Interventions

* commercially available office rubber bands (Alliance® Sterling Rubber Bands, Size 105) OR commercially available medical non-latex bands (Allegience® 1" x 18" x .025") with Velcro adhesion * Plastics disks, hollow (3.5 cm diameter, by 1 cm height) Two bands will be placed just behind the ears laterally, and over the occipital protuberance posteriorly. The plastic inserts will be placed in the temporal fossae bilaterally, under the band to provide adequate tension on the temporal artery.

Compression Headband

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age greater than or equal to 18 years old.
  • Undergoing whole brain radiation therapy, using lateral opposed fields
  • Total planned radiation prescription dose between 30 Gy and 37.5 Gy in 10 to 15 treatments.

You may not qualify if:

  • Current complete or near-complete alopecia (natural or chemotherapy-induced)
  • Concurrent or sequential chemotherapy with an agent known to commonly cause alopecia (Adriamycin, Cytoxan, Ifosfamide, Taxol (greater than 50 mg/m2), or Vincristine).
  • Previous Radiation to the Scalp
  • Any active dermatologic disease affecting the scalp, or temporal arteritis
  • History of severe headaches.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept. of Radiation Oncology, University of Rochester, Med Center

Rochester, New York, 14642, United States

Location

MeSH Terms

Conditions

Alopecia

Condition Hierarchy (Ancestors)

HypotrichosisHair DiseasesSkin DiseasesSkin and Connective Tissue DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Michael Milano, MD, PhD

    University of Rochester

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assoc Professor, Radiation Oncology

Study Record Dates

First Submitted

October 12, 2012

First Posted

October 17, 2016

Study Start

May 1, 2012

Primary Completion

August 1, 2014

Study Completion

August 1, 2014

Last Updated

February 28, 2017

Record last verified: 2017-02

Data Sharing

IPD Sharing
Will share

Researchers can contact the PI to obtain IPD with collaboration.

Locations